Transcranial magnetic stimulation-evoked electroencephalography responses as biomarkers for epilepsy: A review of study design and outcomes.


Journal

Human brain mapping
ISSN: 1097-0193
Titre abrégé: Hum Brain Mapp
Pays: United States
ID NLM: 9419065

Informations de publication

Date de publication:
01 06 2023
Historique:
revised: 23 12 2022
received: 24 09 2022
accepted: 21 02 2023
medline: 12 5 2023
pubmed: 11 3 2023
entrez: 10 3 2023
Statut: ppublish

Résumé

Transcranial magnetic stimulation (TMS) with electroencephalography (EEG), that is TMS-EEG, may assist in managing epilepsy. We systematically reviewed the quality of reporting and findings in TMS-EEG studies on people with epilepsy and healthy controls, and on healthy individuals taking anti-seizure medication. We searched the Cochrane Library, Embase, PubMed and Web of Science databases for original TMS-EEG studies comparing people with epilepsy and healthy controls, and healthy subjects before and after taking anti-seizure medication. Studies should involve quantitative analyses of TMS-evoked EEG responses. We evaluated the reporting of study population characteristics and TMS-EEG protocols (TMS sessions and equipment, TMS trials and EEG protocol), assessed the variation between protocols, and recorded the main TMS-EEG findings. We identified 20 articles reporting 14 unique study populations and TMS methodologies. The median reporting rate for the group of people with epilepsy parameters was 3.5/7 studies and for the TMS parameters was 13/14 studies. TMS protocols varied between studies. Fifteen out of 28 anti-seizure medication trials in total were evaluated with time-domain analyses of single-pulse TMS-EEG data. Anti-seizure medication significantly increased N45, and decreased N100 and P180 component amplitudes but in marginal numbers (N45: 8/15, N100: 7/15, P180: 6/15). Eight articles compared people with epilepsy and controls using different analyses, thus limiting comparability. The reporting quality and methodological uniformity between studies evaluating TMS-EEG as an epilepsy biomarker is poor. The inconsistent findings question the validity of TMS-EEG as an epilepsy biomarker. To demonstrate TMS-EEG clinical applicability, methodology and reporting standards are required.

Identifiants

pubmed: 36896753
doi: 10.1002/hbm.26260
pmc: PMC10171534
doi:

Substances chimiques

Biomarkers 0

Types de publication

Systematic Review Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3446-3460

Informations de copyright

© 2023 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.

Références

PLoS Comput Biol. 2018 Jul 17;14(7):e1006177
pubmed: 30016315
Clin Neurophysiol. 2022 Jan;133:83-93
pubmed: 34814019
Sci Rep. 2022 Feb 4;12(1):1919
pubmed: 35121751
Hum Brain Mapp. 2009 Apr;30(4):1387-96
pubmed: 18537115
Epilepsy Behav. 2019 Apr;93:102-112
pubmed: 30875639
Front Neurosci. 2017 Oct 20;11:585
pubmed: 29104528
J Neurosci Methods. 2022 Mar 15;370:109486
pubmed: 35074394
Hum Brain Mapp. 2019 Mar;40(4):1276-1289
pubmed: 30549127
Brain Topogr. 2018 Nov;31(6):917-930
pubmed: 29943242
Neuroimage. 2017 Dec;163:1-12
pubmed: 28917695
Sci Rep. 2019 Nov 19;9(1):17057
pubmed: 31745223
Brain Topogr. 2019 Jan;32(1):17-27
pubmed: 30019114
Epilepsia. 2000 Jun;41(6):694-704
pubmed: 10840401
Brain Stimul. 2018 Jul - Aug;11(4):818-827
pubmed: 29572124
Neuroimage. 2014 Dec;103:152-162
pubmed: 25245814
Brain Stimul. 2018 Sep - Oct;11(5):1063-1070
pubmed: 29709505
Epilepsia. 2008 Mar;49(3):470-80
pubmed: 18028404
Br J Clin Pharmacol. 2022 Jun;88(6):2926-2937
pubmed: 35028950
J Clin Neurosci. 2016 Sep;31:10-4
pubmed: 27394378
Epilepsy Res. 2011 Sep;96(1-2):123-31
pubmed: 21726980
Brain Topogr. 2022 Nov;35(5-6):583-598
pubmed: 36289133
Biol Psychiatry. 2003 Aug 1;54(3):388-98
pubmed: 12893113
Brain Stimul. 2018 May - Jun;11(3):536-544
pubmed: 29342443
Brain Stimul. 2021 Mar-Apr;14(2):304-315
pubmed: 33516859
Ann Neurol. 2015 Mar;77(3):487-503
pubmed: 25858773
Ann Clin Transl Neurol. 2022 Apr;9(4):540-551
pubmed: 35297209
Nat Rev Neurol. 2021 Sep;17(9):529-544
pubmed: 34312533
Brain. 1998 Sep;121 ( Pt 9):1661-7
pubmed: 9762955
Brain Stimul. 2019 May - Jun;12(3):787-790
pubmed: 30738777
Stroke. 2005 Dec;36(12):2648-53
pubmed: 16269647
Epilepsy Res. 2013 Sep;106(1-2):103-12
pubmed: 23642573
Lancet Neurol. 2016 Jan;15(1):106-15
pubmed: 26549780
J Neurosci Methods. 2022 Dec 1;382:109693
pubmed: 36057330
Brain Stimul. 2020 Nov - Dec;13(6):1580-1587
pubmed: 32949780
Sci Rep. 2021 Apr 14;11(1):8159
pubmed: 33854132
Psychophysiology. 2015 Aug;52(8):997-1009
pubmed: 25903295
Neuroimage. 2019 Jan 15;185:300-312
pubmed: 30347282
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Clin Neurophysiol. 2016 Sep;127(9):3025-3032
pubmed: 27472537
J Neurosci Methods. 2012 Jul 30;209(1):212-8
pubmed: 22743800
J Neurol Sci. 2018 Jul 15;390:172-177
pubmed: 29801881
Exp Brain Res. 2017 Jan;235(1):69-81
pubmed: 27628235
J Neurosci Methods. 2014 Sep 30;235:298-307
pubmed: 25075801
Neuropsychopharmacology. 2018 Oct;43(11):2277-2284
pubmed: 29849055
Hum Brain Mapp. 2023 Jun 1;44(8):3446-3460
pubmed: 36896753
J Neurosci. 2014 Apr 16;34(16):5603-12
pubmed: 24741050
Cephalalgia. 2006 Jul;26(7):801-8
pubmed: 16776694
Clin Neurophysiol. 2012 Sep;123(9):1698-704
pubmed: 22647458
Clin Neurophysiol. 2017 Feb;128(2):367-381
pubmed: 28007469
Brain Sci. 2021 Jan 22;11(2):
pubmed: 33499330
J Neurosci Methods. 2022 Mar 1;369:109482
pubmed: 35041855
IEEE Trans Neural Syst Rehabil Eng. 2018 Feb;26(2):383-391
pubmed: 29432109
J Affect Disord. 2016 Jan 15;190:566-575
pubmed: 26580570
Brain Topogr. 2015 May;28(3):520-8
pubmed: 23996091
Am J Phys Med Rehabil. 1995 May-Jun;74(3):207-13
pubmed: 7779331
Neuroimage. 2021 Oct 1;239:118272
pubmed: 34144161
Ann Clin Transl Neurol. 2019 Nov;6(11):2164-2174
pubmed: 31568714
Front Neurosci. 2021 Feb 25;15:623692
pubmed: 33732105
Neurology. 1999 Oct 12;53(6):1347-9
pubmed: 10522899
Epilepsia. 2017 Jan;58(1):42-50
pubmed: 27808418
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2681-6
pubmed: 20133802
Brain Stimul. 2013 Nov;6(6):868-76
pubmed: 23651674
Electroencephalogr Clin Neurophysiol. 1997 Aug;105(4):262-8
pubmed: 9284233
Lancet. 1985 May 11;1(8437):1106-7
pubmed: 2860322
Clin Neurophysiol. 2019 May;130(5):802-844
pubmed: 30772238
Neuroimage. 2020 Dec;223:117305
pubmed: 32861789

Auteurs

Silvano R Gefferie (SR)

Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands.
Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.

Diego Jiménez-Jiménez (D)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK.
Chalfont Centre for Epilepsy, Chalfont St Peter, UK.

Gerhard H Visser (GH)

Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands.

Robert M Helling (RM)

Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands.

Josemir W Sander (JW)

Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands.
Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK.
Chalfont Centre for Epilepsy, Chalfont St Peter, UK.
Department of Neurology, West China Hospital of Sichuan University, Chengdu, China.

Simona Balestrini (S)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK.
Chalfont Centre for Epilepsy, Chalfont St Peter, UK.
Neuroscience Department, Meyer Children's Hospital-University of Florence, Florence, Italy.

Roland D Thijs (RD)

Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands.
Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.
Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK.
Chalfont Centre for Epilepsy, Chalfont St Peter, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH